Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Sunshine Biopharma (SBFM) Operating Margin: 2012-2024

Historic Operating Margin for Sunshine Biopharma (SBFM) over the last 11 years, with Dec 2024 value amounting to -16.67%.

  • Sunshine Biopharma's Operating Margin rose 158.00% to -11.54% in Q3 2025 from the same period last year, while for Sep 2025 it was -17.35%, marking a year-over-year decrease of 244.00%. This contributed to the annual value of -16.67% for FY2024, which is 320.00% up from last year.
  • According to the latest figures from FY2024, Sunshine Biopharma's Operating Margin is -16.67%, which was up 16.09% from -19.86% recorded in FY2023.
  • Sunshine Biopharma's 5-year Operating Margin high stood at -16.67% for FY2024, and its period low was -1,068.24% during FY2021.
  • Moreover, its 3-year median value for Operating Margin was -19.86% (2023), whereas its average is -219.29%.
  • As far as peak fluctuations go, Sunshine Biopharma's Operating Margin skyrocketed by 223,007bps in 2020, and later crashed by 26,040bps in 2021.
  • Over the past 5 years, Sunshine Biopharma's Operating Margin (Yearly) stood at -807.83% in 2020, then crashed by 26,040bps to -1,068.24% in 2021, then soared by 44,690bps to -621.33% in 2022, then skyrocketed by 60,147bps to -19.86% in 2023, then soared by 320bps to -16.67% in 2024.